Thursday, October 2, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Medicine

CU Anschutz Scientist Awarded NIH Grant to Explore Earthworm Hemoglobin as an Alternative to Red Blood Cells in Organ Perfusion

October 2, 2025
in Medicine
Reading Time: 4 mins read
0
65
SHARES
590
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

In a groundbreaking advancement poised to reshape organ transplantation and preservation, Heiko Yang, MD, PhD, assistant professor of urology at the University of Colorado Anschutz Department of Surgery, has secured a prestigious grant from the National Institutes of Health (NIH) to refine his innovative discovery: a blood substitute derived from earthworm hemoglobin capable of maintaining the viability of organs outside the human body. This development addresses a long-standing challenge in transplant medicine—overcoming the limitations imposed by the use of donated blood in organ preservation—and may herald a new era where organs remain viable for longer durations, potentially days, prior to transplantation or research.

Current clinical protocols typically rely on donor blood to perfuse and sustain organs ex vivo during transport and prior to implantation. However, human blood, while biologically optimized for oxygen transport in vivo, is fraught with significant practical drawbacks in the context of organ preservation. Blood products are scarce, costly, have a limited shelf life, and are prone to rapid degradation when circulated through mechanical perfusion devices designed to imitate cardiac and pulmonary functions. Furthermore, red blood cells themselves, the principal oxygen carriers, are fragile; they lyse under mechanical stress, releasing toxic free radicals and hemoglobin fragments which can exacerbate organ damage and inflammation during perfusion.

Dr. Yang’s research circumvents these challenges by harnessing a unique hemoglobin-like molecule derived from earthworms. This molecule, unlike mammalian hemoglobin, boasts exceptional shelf stability and a molecular structure that enables effective oxygen transport without the typical vulnerability to oxidative damage or mechanical rupture. Collaborating with Jake Elmer, PhD, at Villanova University, an expert in earthworm hemoglobin, Dr. Yang conducted pilot studies demonstrating that this bio-derived oxygen carrier could successfully sustain the metabolic demands of perfused kidneys outside the body. These encouraging results laid the foundation for the current NIH grant, which aims to optimize the formulation, concentration, and chemical stabilization methods necessary to extend organ viability significantly.

The implications of developing a robust, off-the-shelf blood substitute extend far beyond transplantation logistics. By eliminating reliance on donated human blood products, the medical and research communities could gain unprecedented access to consistent, reproducible perfusates that ensure organ tissue integrity over extended periods. This advancement would not only enhance transplant outcomes by improving organ quality but also accelerate the pace of biomedical investigations involving ex vivo organ models, enabling experiments previously constrained by the unpredictability of blood supply and viability.

The scientific community has long sought synthetic or alternative blood substitutes to address the critical shortages and logistic complications associated with human blood. Attempts with perfluorocarbons, modified hemoglobins, and other oxygen carriers have encountered numerous setbacks, including toxicity, inadequate oxygen delivery, and immune reactions. Dr. Yang’s approach, leveraging a natural yet structurally distinct oxygen carrier from earthworms, represents a novel paradigm that melds biological compatibility with chemical robustness. The proposal to stabilize and fine-tune this hemoglobin-like molecule could circumvent the pitfalls that have beleaguered previous blood substitute candidates.

A pivotal aspect of the ongoing research involves dissecting the biochemical and biophysical properties of the earthworm-derived hemoglobin in the context of organ perfusion. Detailed characterization of oxygen affinity, molecular size, and circulatory dynamics will inform the determination of ideal perfusion parameters. Dr. Yang’s team plans to explore whether additional chemical modifications are required to enhance stability, prevent aggregation, or modulate oxygen release kinetics, all of which are critical to mimic physiological oxygenation without eliciting adverse reactions in human tissue.

If successful, a perfusion system powered by this earthworm hemoglobin substitute could revolutionize organ transplantation infrastructure. Presently, organ viability is often constrained to a narrow window—hours at best—severely limiting the geographic reach of donor-recipient matching and contributing to significant organ discard rates. An extended preservation window enabled by a stable, efficient oxygen carrier would allow for broader donor pools, improved surgical scheduling flexibility, and potentially better immunological matching, thereby improving graft survival rates.

Moreover, beyond the transplanted kidney model, this technology holds promise across multiple organ systems, including liver, heart, and lungs, each with distinct metabolic requirements. The versatility of the earthworm hemoglobin product could pave the way for universal preservation solutions adaptable to various perfusion systems and organ types. This would mark a substantial leap forward, replacing the inconsistent and variable human blood supply with a reliable, ready-to-use alternative optimized for tissue oxygenation and metabolic support.

Researchers underline that this effort embodies a “high-risk, high-reward” strategy, reflecting both the novelty and transformative potential of the approach. The two-year NIH grant supports essential experiments and optimization studies, providing critical data needed to secure subsequent funding aimed at large-scale validation and translational clinical application. The wider transplantation and medical research communities watch with keen interest, hopeful that this earthworm-derived blood substitute will surmount a problem that has lingered unaddressed for decades.

In sum, Dr. Heiko Yang and his collaborators are charting a path that could drastically improve the efficiency and outcomes of organ transplantation. Their work challenges traditional paradigms about oxygen delivery outside the human body and offers a futuristic vision where organs can be reliably preserved without the constraints of blood availability. This innovation promises to enhance both clinical care for transplant recipients and experimental science that relies on viable ex vivo organ models, marking a pivotal moment in the quest to extend the reach and efficacy of transplant medicine.

Subject of Research:
Organ preservation and perfusion using an earthworm hemoglobin-based blood substitute for improving organ transplant viability.

Article Title:
Revolutionizing Organ Transplantation: Earthworm Hemoglobin as a Sustainable Blood Substitute for Enhanced Organ Preservation

News Publication Date:
Not explicitly mentioned.

Web References:
University of Colorado Anschutz Department of Surgery – https://medschool.cuanschutz.edu/surgery
Urology Division – https://medschool.cuanschutz.edu/surgery/divisions-centers-affiliates/urology

Keywords:
Organ transplantation, blood substitute, earthworm hemoglobin, organ perfusion, ex vivo organ preservation, NIH grant, transplantation medicine, kidney preservation, oxygen carrier, blood product alternatives, organ viability, medical innovation.

Tags: alternatives to human blood in perfusionblood products scarcity and costchallenges in transplant medicineearthworm hemoglobin as blood substituteex vivo organ viabilityinnovative discoveries in organ preservationlimitations of donated blood for transplantsmaintaining organ viability outside the bodymechanical perfusion device challengesNIH grant for organ preservationorgan transplantation advancementsred blood cell fragility in organ preservation
Share26Tweet16
Previous Post

Scientists Create Fast, Scalable In Planta Directed Evolution Platform

Next Post

Registration and Scientific Program Now Open for Upcoming Plasma Physics Conference

Related Posts

blank
Medicine

Bipolar Configurations in Adult Spine Deformity Analysis

October 2, 2025
blank
Medicine

CNIO Researchers Develop the “Human Repairome”: A Comprehensive Catalogue of DNA “Scars” Paving the Way for Personalized Cancer Therapies

October 2, 2025
blank
Medicine

NJIT Study Reveals Vision Therapy Restores Clarity from Concussion-Induced Double and Blurred Vision

October 2, 2025
blank
Medicine

Mental Health Advances Most Strongly Predict Increased Life Satisfaction

October 2, 2025
blank
Medicine

EBMT Unveils 2025 Clinical Practice Guidelines for Hematopoietic Cell Transplantation and CAR-T Therapy

October 2, 2025
blank
Medicine

Childhood Experiences Shape Nurses’ Burnout and Depression

October 2, 2025
Next Post
blank

Registration and Scientific Program Now Open for Upcoming Plasma Physics Conference

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27562 shares
    Share 11022 Tweet 6889
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    970 shares
    Share 388 Tweet 243
  • Bee body mass, pathogens and local climate influence heat tolerance

    646 shares
    Share 258 Tweet 162
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    513 shares
    Share 205 Tweet 128
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    477 shares
    Share 191 Tweet 119
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Depression Alters Theta, Alpha in Memory Tasks
  • Validating Persian Experiential Avoidance Scale for Psychological Inflexibility
  • Bipolar Configurations in Adult Spine Deformity Analysis
  • Identifying Pharmaceuticals in Water Near Informal Settlements

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,186 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading